The Pharmaceutical Care Management Association is beginning the DrugBenefitSolutions national campaign, in which it seeks to explain how pharmacy benefits managers are helping to reduce the price of medications and assist consumers, as well as employers and unions. Read More »
Togo became the first country in Africa recognized by the World Health Organization for eliminating lymphatic filariasis, also known as elephantiasis, as a public health problem. Read More »
The American Society of Health-System Professionals (ASHP) recently announced that Michael Cohen, operations officer for the investigations branch of the Department of Health and Human Services (HHS) Office of Inspector General (OIG) in Washington, D.C., believes clinicians need to not just look at opioids but also at non-controlled drugs when trying to understand drug abuse. Read More »
The American Society of Health-System Professionals recently launched a pharmacy project aimed at training emergency medical services and law enforcement personnel on how to deliver naloxone to opioid-overdosed individuals. Read More »
The Academy of Managed Care Pharmacy (AMCP) recently applauded Rep. Brett Guthrie's (R-KY) Pharmaceutical Information Exchange (PIE) Act of 2017 and its efforts toward its passage. Read More »
Praising President Donald Trump’s recent executive order to redirect the previous administration’s energy regulations, a spokesman for the grassroots Americans for Prosperity (AFP) has issued a statement of support. Read More »
Pharmacists and the difficult balance they must keep between patients suffering from chronic pain and the prevalence opioid abuse was the topic of a recent special issue of the Journal of the American Pharmacists Association Read More »
Prescription drug costs battles are far from over as PCMA calls for the drug lobby to stop deflecting blame in an effort to maintain profit margins. Read More »
Acorda Therapeutics Inc. recently announced that the United States District Court for the District of Delaware invalidated four of its patents related to Ampyra extended release tablets. Read More »
Senators pushing for changes to Medicare Part D drug pricing reporting requirements should be wary of messing with the program, according to a former administrator of the Centers for Medicare and Medicaid Services. Read More »
Sen. Ron Wyden (D-OR) last week introduced legislation that he says would increase pricing "transparency" among pharmacy benefit managers. Read More »
The Biosimilars Council is hoping the Supreme Court will acknowledge the savings that biosimilar medications can offer to both patients and health systems. Read More »
U.S. House Judiciary Chairman Bob Goodlatte (R-VA) has sent letters to the American Bar Association and every state bar association, urging the organizations to adopt requirements for warnings on trial lawyer advertisements that urge patients to discontinue the use of some medicines. Read More »
U.S. Congressmen Doug Collins (R-GA) and Dave Loebsack (D-IA) last week introduced a bill -- H.R. 1316, the Prescription Drug Price Transparency Act -- that they say would "require greater transparency from pharmacy benefit managers (PBMs)." In introducing the bill, the congressmen, along with Rep. Buddy Carter (R-GA) and others, took to the House floor to deliver what Drug Channels' Dr. Adam Fein referred to as a "60-minute rant" against PBMs. Read More »
The Pharmaceutical Research and Manufacturers of America submitted comments this month to the 2017 Special 301 Report. Read More »
The U.S. Federal Trade Commission has filed a civil action suit against a subsidiary of Shire, PLC, as part of a citizen petition submission regarding antibiotic Vancocin. Read More »
The Missoula Urban Indian Health Center is participating in offering education, care coordination and patient-navigator services to more than 30 Indian tribes. Read More »
The Department of Veterans Affairs is looking to expand pharmacists’ roles as health care providers for veterans living in rural communities. Read More »
Recently passed legislation now allows Medicare to pay pharmacists for services provided to beneficiaries in underserved communities. Read More »
The Association for Accessible Medicines (AAM) recently announced that its president and CEO, Chip Davis, made a statement regarding the confirmation of Tom Price as Secretary of Health and Human Services. Read More »
Alerts Sign-up
